{"id":28999,"date":"2012-04-27T04:50:44","date_gmt":"2012-04-27T08:50:44","guid":{"rendered":"http:\/\/countingpips.com\/fx\/?p=28999"},"modified":"2012-04-27T04:50:44","modified_gmt":"2012-04-27T08:50:44","slug":"eli-lilly-tops-estimates-and-boosts-guidance","status":"publish","type":"post","link":"https:\/\/www.investmacro.com\/fx\/2012\/04\/27\/eli-lilly-tops-estimates-and-boosts-guidance\/","title":{"rendered":"Eli Lilly Tops Estimates And Boosts Guidance"},"content":{"rendered":"<p><div id=\"grabDiv1767162\"><object id=\"GrabPlayer1767162\" width=\"542\" height=\"304\" type=\"application\/x-shockwave-flash\" align=\"middle\" data=\"http:\/\/player.grabnetworks.com\/swf\/GrabOSMFPlayer.swf?id=1767162&#038;content=v570e3360068c1f637da84d39ba184c047a4878be&#038;tgt=grabnetworks\"><param name=\"quality\" value=\"high\"\/><param name=\"allowScriptAccess\" value=\"always\"\/><param name=\"allowFullScreen\" value=\"true\"\/><param name=\"menu\" value=\"false\"\/><param name=\"wmode\" value=\"transparent\"\/><param name=\"movie\" value=\"http:\/\/player.grabnetworks.com\/swf\/GrabOSMFPlayer.swf?id=1767162&#038;content=v570e3360068c1f637da84d39ba184c047a4878be&#038;tgt=grabnetworks\"\/><\/object><\/p>\n<div id=\"overlay-adzone\" style=\"overflow:hidden; position:relative\"><\/div>\n<\/div>\n<p>Eli Lilly (NYSE:LLY) reported Q1 EPS of $0.92, topping estimates of $0.79.Revenues in the quarter came in at $5.6 billion, vs. estimates of $5.39 billion.The company still sees annual revenues of $21.8 billion &#8211; $22.8 billion, vs. estimates of $22.4 billion.However, Lilly now sees 2012 EPS of $3.15-$3.30, vs. its prior guidance of $3.10-$3.20 as of Jan. 31, and estimates of $3.18.<\/p>\n<p><img src='http:\/\/cache.thenewsroom.com\/financial_news_network\/2012\/04\/27\/1_s8018zfl_thumb.jpg' \/><\/p>\n<p><!--post_img[http:\/\/cache.thenewsroom.com\/financial_news_network\/2012\/04\/27\/1_s8018zfl_preview.jpg]--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Eli Lilly (NYSE:LLY) reported Q1 EPS of $0.92, topping estimates of $0.79.Revenues in the quarter came in at $5.6 billion, vs. estimates of $5.39 billion.The company still sees annual revenues of $21.8 billion &#8211; $22.8 billion, vs. estimates of $22.4 billion.However, Lilly now sees 2012 EPS of $3.15-$3.30, vs. its prior guidance of $3.10-$3.20 as &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.investmacro.com\/fx\/2012\/04\/27\/eli-lilly-tops-estimates-and-boosts-guidance\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Eli Lilly Tops Estimates And Boosts Guidance&#8221;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-28999","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/posts\/28999","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/comments?post=28999"}],"version-history":[{"count":0,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/posts\/28999\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/media?parent=28999"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/categories?post=28999"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/tags?post=28999"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}